Drug Shortage Report for TEVA-LETROZOLE

Last updated on 2020-11-19 History
Report ID 105590
Drug Identification Number 02343657
Brand name TEVA-LETROZOLE
Common or Proper name LETROZOLE 2.5MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) LETROZOLE
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code L02BG
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-02-06
Estimated end date 2021-01-31
Actual end date
Shortage status Actual shortage
Updated date 2020-11-19
Company comments Allocating to 100% of our market.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2020-11-19 French Compare
v15 2020-11-19 English Compare
v14 2020-09-17 French Compare
v13 2020-09-17 English Compare
v12 2020-09-10 French Compare
v11 2020-09-10 English Compare
v10 2020-09-10 French Compare
v9 2020-09-10 English Compare
v8 2020-07-23 French Compare
v7 2020-07-23 English Compare
v6 2020-07-09 French Compare
v5 2020-07-09 English Compare
v4 2020-05-08 French Compare
v3 2020-05-08 English Compare
v2 2020-02-07 French Compare
v1 2020-02-07 English Compare